NYU PTSD Treatment Study

Do you have flashbacks or nightmares?

Do you avoid talking, thinking, or being in situations that remind you of the trauma?

Do you feel distant or cut off from others?

You may be eligible to participate in a medication research study for Post-Traumatic Stress Disorder at NYU Langone Health (IRB Study #: s17-00388).

The purpose of this research study is to see whether Losartan, a medication FDA-approved and commonly prescribed for the treatment of high blood pressure, may be effective for treating Posttraumatic Stress Disorder (PTSD). After medical and psychiatric evaluations are completed, eligible participants are randomly assigned to one of two study medications lasting approximately 12 weeks: Losartan or a Placebo (a sugar pill without active medication).

Key Eligibility Criteria: Adults ages 18 - 70 who have PTSD or Post-traumatic Stress Symptoms; PTSD symptoms experienced for at least three months.

Your information will remain private. They will ask you for a blood sample. You will receive compensation for your time. Click to see if you qualify: https://openredcap.nyumc.org/apps/redcap/surveys/?s=377R473DTM

Get Help Bulletin Board